Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|July 21, 2016
Discovery of potent wall teichoic acid early stage inhibitorsMarc A Labroli, John P Caldwell, Christine Yang, et al.Bioorganic & Medicinal Chemistry Letters|April 1, 2009
Identification of 3-substituted N-benzhydryl-nortropane analogs as nociceptin receptor ligands for the management of cough and anxietyShu-Wei Yang, Ginny Ho, Deen Tulshian, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2011
Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophreniaShu-Wei Yang, Jennifer Smotryski, William T McElroy, et al.Bioorganic & Medicinal Chemistry Letters|August 13, 2014
Discovery of pyrrolo-benzo-1,4-diazines as potent Na(v)1.7 sodium channel blockersGinny D Ho, Deen Tulshian, Ana Bercovici, et al.Bioorganic & Medicinal Chemistry Letters|October 8, 2014
Bioavailable pyrrolo-benzo-1,4-diazines as Na(v)1.7 sodium channel blockers for the treatment of painShu-Wei Yang, Ginny D Ho, Deen Tulshian, et al.Bioorganic & Medicinal Chemistry Letters|August 31, 2016
Benzimidazole analogs as WTA biosynthesis inhibitors targeting methicillin resistant Staphylococcus aureusShu-Wei Yang, Jianping Pan, Christine Yang, et al.Bioorganic & Medicinal Chemistry Letters|January 7, 2012
The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of SchizophreniaGinny D Ho, Shu-Wei Yang, Jennifer Smotryski, et al.Science Translational Medicine|March 11, 2016
TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococciSang Ho Lee, Hao Wang, Marc Labroli, et al.Journal of Medicinal Chemistry|March 22, 2017
Can We Make Small Molecules Lean? Optimization of a Highly Lipophilic TarO InhibitorMihirbaran Mandal, Zheng Tan, Christina Madsen-Duggan, et al.Journal of Medicinal Chemistry|December 8, 2022
Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical CandidatesMihirbaran Mandal, Li Xiao, Weidong Pan, et al.Pageof 4